Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...
New research urges reclassifying schizophrenia as a neurodevelopmental syndrome—advancing diagnosis, care, and public ...
Everyday Health on MSN
Why histological healing is the new benchmark for your ulcerative colitis
For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...
A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
Richardson, MD, gave an overview of the ways that CELMoDs are poised to impact the landscape of multiple myeloma treatment at ...
Too frequently, clinicians think all they need to say is, ‘I know better,’ and that’s not what patients need to hear,” said ...
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results